Monevue Monevue

Aura Biosciences, Inc. AURA 11.78 Aura Biosciences, Inc.

Home
⇒ 
Stock List ⇒ Aura Biosciences, Inc.
Range:5.99-12.35Vol Avg:159295Last Div:0Changes:0.65
Beta:0.37Cap:0.45BCurrency:USDExchange:NASDAQ
Sector:HealthcareIPO:Fri Oct 29 2021Empoloyees:88
CUSIP:05153U107CIK:0001501796ISIN:US05153U1079Country:US
CEO:Dr. Elisabet de los Pinos Ph.D.Website:https://www.aurabiosciences.com
Aura Biosciences, Inc. operates as a biotechnology company that develops therapies to treat cancer. The company develops virus-like drug conjugates (VDC) technology platform for the treat tumors of high unmet need in ocular and urologic oncology. It develops AU-011, a VDC candidate for the treatment of primary choroidal melanoma. It also develops AU-011 in additional ocular oncology indications, including choroidal metastases. The company was incorporated in 2009 and is headquartered in Cambridge, Massachusetts.

Stock Details

AURA 23

George Farmer·Fri Oct 18 2024
Scotiabank

AURA 22

Ed White II·Fri Oct 18 2024
H.C. Wainwright

AURA 24

Julian Harrison·Fri Oct 18 2024
BTIG

AURA 21

Edward White·Thu Jul 25 2024
H.C. Wainwright
Monevue Monevue

About The Monevue

Stock News

Markets

Best Buys

The content provided on this site is for informational purposes only and does not constitute financial, investment, or professional advice. We are not registered investment advisors or financial planners, and we do not provide recommendations or advice on buying, selling, or holding any particular stocks or securities. Any investment decisions should be made based on your own research and consultation with a qualified financial professional. We are not responsible for any financial loss or damages incurred from reliance on the information provided on this site. Please invest responsibly and seek professional advice when needed.
DMCA.com Protection Status • Powered by StackThrow